Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 301.37B, Merck(MRK) trades at $122.02. The stock has a price-to-earnings ratio of 33.85 and currently yields dividends of 2.8%.
As of 2026-06-05, Merck(MRK) stock has fluctuated between $120.36 and $123.45. The current price stands at $122.02, placing the stock +1.4% above today's low and -1.2% off the high.
The Merck(MRK)'s current trading volume is 5.32M, compared to an average daily volume of 10.71M.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $76.66.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $76.66.
MRK News
In late May 2026, Merck reported that its investigational KRAS G12C inhibitor calderasib (MK-1084), when combined with KEYTRUDA, received FDA Breakthrough Thera...
Explore the exciting world of Merck (NYSE: MRK) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain...
Merck (MRK) told Bloomberg in an emailed statement that it will pay more than $50M to settle over 200 lawsuits relating to its Gardasil HPV vaccine. The deal re...
Analyst ratings
70%
of 30 ratingsMore MRK News
A securities fraud class action lawsuit has been filed against Merck (NYSE:MRK) over alleged misleading statements about product performance and competition in...
Pfizer vs Merck: Chasing High Yield vs Higher Returns By Vandita Jadeja Published Jun 3, 10:06AM EDT Quick Read PFE yields 6.58% at a forward P/E of 9, while...
Key Points This biotech is making solid progress with several pipeline candidates. It could have a stronger lineup of approved products within a few years. 1...
Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Merck & Company, retaining the price target of $130.00. Unlock trusted, data-ba...
Moderna (MRNA) and Merck (MRK), known as MSD outside of the United States and Canada, announced detailed results from a planned five-year follow-up analysis of...
A promising new cancer drug helped reduce the risk of death by 34% in patients with the most common form of lung cancer, but investors appeared to be ambivalent...
Geoff Meacham, an analyst from Citi, maintained the Hold rating on Merck & Company. The associated price target remains the same with $125.00. Unlock trusted,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.